PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BMEZ vs. HELX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BMEZ and HELX is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

BMEZ vs. HELX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
6.51%
-7.43%
BMEZ
HELX

Key characteristics

Sharpe Ratio

BMEZ:

0.90

HELX:

-0.10

Sortino Ratio

BMEZ:

1.35

HELX:

-0.02

Omega Ratio

BMEZ:

1.16

HELX:

1.00

Calmar Ratio

BMEZ:

0.33

HELX:

-0.04

Martin Ratio

BMEZ:

3.25

HELX:

-0.34

Ulcer Index

BMEZ:

4.01%

HELX:

5.55%

Daily Std Dev

BMEZ:

14.46%

HELX:

18.39%

Max Drawdown

BMEZ:

-46.05%

HELX:

-56.33%

Current Drawdown

BMEZ:

-30.20%

HELX:

-49.95%

Returns By Period

In the year-to-date period, BMEZ achieves a 12.82% return, which is significantly higher than HELX's -4.59% return.


BMEZ

YTD

12.82%

1M

-1.43%

6M

5.65%

1Y

12.28%

5Y*

N/A

10Y*

N/A

HELX

YTD

-4.59%

1M

1.83%

6M

-7.99%

1Y

-3.77%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BMEZ vs. HELX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BMEZ, currently valued at 0.90, compared to the broader market-4.00-2.000.002.000.90-0.10
The chart of Sortino ratio for BMEZ, currently valued at 1.35, compared to the broader market-4.00-2.000.002.004.001.35-0.02
The chart of Omega ratio for BMEZ, currently valued at 1.16, compared to the broader market0.501.001.502.001.161.00
The chart of Calmar ratio for BMEZ, currently valued at 0.33, compared to the broader market0.002.004.006.000.33-0.04
The chart of Martin ratio for BMEZ, currently valued at 3.25, compared to the broader market0.0010.0020.003.25-0.34
BMEZ
HELX

The current BMEZ Sharpe Ratio is 0.90, which is higher than the HELX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of BMEZ and HELX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.90
-0.10
BMEZ
HELX

Dividends

BMEZ vs. HELX - Dividend Comparison

BMEZ's dividend yield for the trailing twelve months is around 11.40%, while HELX has not paid dividends to shareholders.


TTM2023202220212020
BMEZ
BlackRock Health Sciences Trust II
11.40%10.81%11.28%6.75%3.14%
HELX
Franklin Genomic Advancements ETF
0.00%0.00%0.00%0.24%0.12%

Drawdowns

BMEZ vs. HELX - Drawdown Comparison

The maximum BMEZ drawdown since its inception was -46.05%, smaller than the maximum HELX drawdown of -56.33%. Use the drawdown chart below to compare losses from any high point for BMEZ and HELX. For additional features, visit the drawdowns tool.


-50.00%-45.00%-40.00%-35.00%-30.00%JulyAugustSeptemberOctoberNovemberDecember
-30.20%
-49.95%
BMEZ
HELX

Volatility

BMEZ vs. HELX - Volatility Comparison

The current volatility for BlackRock Health Sciences Trust II (BMEZ) is 4.92%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 6.51%. This indicates that BMEZ experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%JulyAugustSeptemberOctoberNovemberDecember
4.92%
6.51%
BMEZ
HELX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab